Rumunsko -
rumunština -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida sandoz 7,5 mg
synthon hispania, s.l. - spania - lenalidomidum - caps. - 7,5mg - imunosupresoare alte imunosupresoare
Rumunsko -
rumunština -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida labormed 10 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 10mg - imunosupresoare alte imunosupresoare
Rumunsko -
rumunština -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida labormed 15 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 15mg - imunosupresoare alte imunosupresoare
Rumunsko -
rumunština -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida labormed 2,5 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 2,5mg - imunosupresoare alte imunosupresoare
Rumunsko -
rumunština -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida labormed 20 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 20mg - imunosupresoare alte imunosupresoare
Rumunsko -
rumunština -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida labormed 25 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 25mg - imunosupresoare alte imunosupresoare
Rumunsko -
rumunština -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida labormed 5 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 5mg - imunosupresoare alte imunosupresoare
Rumunsko -
rumunština -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
lenalidomida labormed 7,5 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 7,5mg - imunosupresoare alte imunosupresoare
Moldavsko -
rumunština -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
iodomarin 200 200 mcg comprimate
berlin-chemie ag (menarini group) - amoxicillinum iodidum - comprimate - 200 mcg
Evropská unie -
rumunština -
EMA (European Medicines Agency)
lenalidomide krka d.d. novo mesto (previously lenalidomide krka)
krka, d.d., novo mesto - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - imunosupresoare - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).